Abstract:Abstract Background The SARS-Coronavirus-2 (SARS-CoV-2) invades the respiratory system, causing acute and sometimes severe pulmonary symptoms, but turned out to also act multisystematically with substantial impact on the brain. A growing number of studies suggests a diverse spectrum of neurological manifestations. To investigate the spectrum of symptoms, we here describe the neurological manifestations and complications of patients with proven SARS-CoV-2 infection who have been hospitalized at the RWTH University Hospital Aachen, Germany. Methods Between March and September 2020, we evaluated common symptoms, clinical characteristics, laboratory (including cerebrospinal fluid (CSF) analysis), radiological, and electroencephalography (EEG) data from 53 patients admitted with a positive SARS-CoV-2 polymerase chain reaction (PCR). We used the Montreal Cognitive Assessment Test (MoCA) to screen for cognitive impairment, when feasible. We compared critically ill and non-critically ill patients categorized according to the presence of Acute Respiratory Distress Syndrome (ARDS). Results Major clinical neurological features of hospitalized COVID-19 patients were coordination deficits (74%), cognitive impairment (61.5%), paresis (47%), abnormal reflex status (45%), sensory abnormalities (45%), general muscle weakness and pain (32%), hyposmia (26%), and headache (21%). Patients with ARDS were more severely affected than non-ADRS patients. 29.6% of patients with ARDS presented with subarachnoid bleedings, and 11.1% showed ischemic stroke associated with SARS-CoV-2 infection. Cognitive deficits mainly affected executive functions, attention, language, and delayed memory recall. We obtained cerebrospinal fluid (CSF) by lumbar puncture in nine of the 53 patients, none of which had a positive SARS-CoV-2 PCR. Conclusions In line with previous findings, our results provide evidence for a range of SARS-CoV-2-associated neurological manifestations. 26% of patients reported hyposmia, emphasizing the neuro-invasive potential of SARS-CoV-2, which can enter the olfactory bulb. It can therefore be speculated that neurological manifestations may be caused by direct invasion of the virus in the CNS; however, PCR did not reveal positive intrathecal SARS-CoV-2. Therefore, we hypothesize it is more likely that the para-infectious severe pro-inflammatory impact of COVID-19 is responsible for the neurological deficits including cognitive impairment. Future studies with comprehensive longitudinal assessment of neurological deficits are required to determine potential long-term complications of COVID-19.

Central Nervous System Complications in SARS-CoV-2-infected Patients.

Neurological and Psychiatric Presentations Associated with COVID-19

Neurological complications caused by SARS-CoV-2

Current Clinical Findings of Acute Neurological Syndromes after SARS‐CoV‐2 Infection

Potential of SARS-CoV-2 to Cause CNS Infection: Biologic Fundamental and Clinical Experience

Clinical features of neurological patients with coronavirus 2019: an observational study of one centre

Neurological Manifestations in Critically Ill Patients With COVID-19: A Retrospective Study

High Frequency of Autoantibodies in COVID-19 Patients with Central Nervous System Complications: a Multicenter Observational Study

Immune-mediated neurological syndromes in SARS-CoV-2-infected patients

The neurobiology of SARS-CoV-2 infection

Neurological complications and infection mechanism of SARS-CoV-2

Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study

SARS-CoV-2 Infection in the Central and Peripheral Nervous System-Associated Morbidities and Their Potential Mechanism

Case report: Rare Guillain-Barré syndrome variants and mild encephalitis/encephalopathy with a reversible splenial lesion as the para-infectious manifestations of SARS-CoV-2 infection

COVID-19 and central nervous system interplay: A big picture beyond clinical manifestation

SARS‐CoV‐2‐associated T‐cell infiltration in the central nervous system

Neurological Complications During the Omicron COVID-19 Wave in China: A Cohort Study

Possible mechanism of central nervous system targeting and neurological symptoms of the new-coronavirus (COVID-19): literature review

Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients

COVID-19 and Central Nervous System Manifestations: A Systemic review on Therapeutic Outcome

Neuropsychiatric manifestations of COVID-19, potential neurotropic mechanisms, and therapeutic interventions